Aspira Women's Health Inc. (AWHL) stock
AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.22−0.01 (-2.61%)
Close on Oct 19, 2026Market cap $9.91MP/E –Yield –
Aspira Women's Health enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Aspira Women's Health's enterprise value was $11.67M on Oct 19, 2026, against $18.10M a year earlier. Over the last 5 years it ranged from $1.40M to $191.27M, with a median of $23.29M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $11.67M | -52.2% |
| 2025 | Dec 31, 2025 | $24.40M | +122.0% |
| 2024 | Dec 31, 2024 | $10.99M | -71.5% |
| 2023 | Dec 29, 2023 | $38.54M | +65.5% |
| 2022 | Dec 30, 2022 | $23.29M | -85.1% |
| 2021 | Dec 31, 2021 | $156.52M | -77.0% |
| 2020 | Dec 31, 2020 | $681.44M | +940.9% |
| 2019 | Dec 31, 2019 | $65.47M | +428.7% |
| 2018 | Dec 31, 2018 | $12.38M | -88.7% |
| 2017 | Dec 29, 2017 | $109.76M | +152.6% |
| 2016 | Dec 30, 2016 | $43.46M | -37.6% |
| 2015 | Dec 31, 2015 | $69.64M | +24.6% |
| 2014 | Dec 31, 2014 | $55.91M | +33.3% |
| 2013 | Dec 31, 2013 | $41.93M | +305.5% |
| 2012 | Dec 31, 2012 | $10.34M | – |
| 2011 | Dec 30, 2011 | -$9.86M | – |
See a number that looks wrong?